Nanobiotix S.A. (NBTX)
NASDAQ: NBTX · Real-Time Price · USD
22.65
-0.56 (-2.41%)
At close: Dec 24, 2025, 1:00 PM EST
22.50
-0.15 (-0.66%)
After-hours: Dec 24, 2025, 4:27 PM EST
Nanobiotix Market Cap
Nanobiotix has a market cap or net worth of $1.12 billion as of December 24, 2025. Its market cap has increased by 597.95% in one year.
Market Cap
1.12B
Enterprise Value
1.15B
1-Year Change
597.95%
Ranking
Category
Stock Price
$22.65
Market Cap Chart
Since the IPO on November 21, 2016, Nanobiotix's market cap has increased from $249.91M to $1.12B, an increase of 348.01%. That is a compound annual growth rate of 17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 23, 2025 | 1.13B | 660.54% |
| Dec 31, 2024 | 148.41M | -57.08% |
| Dec 29, 2023 | 345.77M | 156.45% |
| Dec 30, 2022 | 134.83M | -53.41% |
| Dec 31, 2021 | 289.40M | -50.20% |
| Dec 31, 2020 | 581.15M | 179.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 959.53B |
| Johnson & Johnson | 495.78B |
| AbbVie | 404.36B |
| UnitedHealth Group | 294.22B |
| AstraZeneca | 287.19B |
| Novartis AG | 267.64B |
| Merck & Co. | 260.71B |
| Novo Nordisk | 232.28B |